Echosens North America

14/05/2020

New recommendations from the USPSTF recommend screening for infection in adolescents and adults at increased risk for infection.

Learn more:https://www.aafp.org/news/health-of-the-public/20200512uspstfhbvscreen.html

13/05/2020

Join echosens in our next educational webinar as we welcome physician expert Dr. Caroline Apovian, the Director of Nutrition and Weight Management at Boston Medical Center.

Click for details!
https://event.on24.com/wcc/r/2285813/F257B9753848A3739DE609A327F29EAD?partnerref=FB

04/05/2020

The silent liver diseases you need to know about: and .

Never heard of NAFLD or NASH? You aren’t alone and that’s part of the problem.

Potentially affecting the livers of more than 100 million Americans, NAFLD and its more severe form NASH can lead to cirrhosis of the liver and liver cancer if not caught early.

Get the facts so you can prevent these diseases:

Non-alcoholic fatty liver disease (NAFLD) is a spectrum of the disease characterized by the accumulation of lipids in liver cells not associated with the consumption of alcohol. It causes cellular dysfunction and, in some patients, leads to non-alcoholic steatohepatitis (NASH), fibrosis, and cirrhos...

21/04/2020

Fatty liver disease is a chronic liver disease and a rapidly growing problem. Find out how Dr. Richard Gilroy of Intermountain Healthcare's liver transplantation program is addressing this problem.

https://kutv.com/features/health/check-your-health/check-your-health-a-simple-non-invasive-test-can-tell-you-if-you-have-a-fatty-liver

Fatty liver disease is a chronic liver disease and is a rapidly growing problem here in Utah. It’s important to catch this disease early with a simple, non-invasive test and then make the necessary lifestyle changes. Fatty liver disease occurs when the body accumulates too much fat in the live...

16/04/2020

April is . Did you know that an estimated 7% of the US population meets the criteria for alcohol abuse?

These individuals are at an increased risk of developing , the 8th most common cause of mortality in the US.

Find out how FibroScan is positioned to assess liver fibrosis in alcoholic patients:
https://echosens.us/alcoholic-liver-disease/

14/04/2020

From all of us at Echosens, thank you to all the doctors and healthcare professionals for everything you are doing to fight .

13/04/2020

Worldwide, 292M people are chronically infected with chronic hepatitis B. Find out the impact has on these individuals in the latest webinar from Dr. Robert Gish, the Medical Director of The Hepatitis B Foundation.

Learn More:
https://event.on24.com/wcc/r/2241793/0CCD9EB36585B4BF05B826BE49193184?partnerref=FB

07/04/2020

Discover new innovative tools that support diagnosis efficiency, improve accuracy and reduce costs in the battle against .

https://echosens.us/battling-liver-disease/

03/04/2020

Join Echosens as we welcome Dr. Robert Gish, the Medical Director for the Hepatitis B Foundation, as he presents new findings on the intersection of , and .

Learn More: https://event.on24.com/wcc/r/2241793/0CCD9EB36585B4BF05B826BE49193184?partnerref=FB

31/03/2020

Echosens proudly announces its collaboration with MetaPhy Health to support turn-key, comprehensive management services to practices for their patients with .

Learn More: https://echosens.us/echosens-and-metaphy-health-collaborate/

Expanding Patient-Centered Care for Chronic Liver Disease Management: Gastroenterology Specialists Improve Outcomes, Lower Costs & Enhance Practice Performance

24/03/2020

Today is !

Did you know that the prevalence of has increased in parallel with the epidemics of and ?

Help us raise awareness of the relationship between and .

Learn more:
https://bit.ly/3drtMc4

24/03/2020

Echosens has arranged an independent assessment conducted by Santa Barbara Actuaries Inc. (SBA), an actuarial and healthcare consulting firm specializing in cutting-edge predictive modeling and analytics, to determine the cost savings of care models implemented at the .

Learn More: https://echosens.us/echosens-engages-santa-barbara-actuaries-to-demonstrate-cost-effectiveness-of-fibroscan/

Echosens engages Santa Barbara Actuaries to demonstrate the cost-effectiveness of FibroScan non-invasive technology.